Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 63 (RPL7AP63)

Target
RPL7AP63
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L7a pseudogene 63 (RPL7AP63) is a processed pseudogene that shares sequence similarity with the gene encoding ribosomal protein L7a (RPL7A). However, it is not a functional gene and does not encode a protein product or function as a therapeutic target. It is one of multiple pseudogenes derived from the ribosomal protein L7a (RPL7A) gene. Pseudogenes are genetic sequences similar to functional genes but are generally non-coding and do not produce active protein products. RPL7AP63 does not encode a functional ribosomal protein and therefore has no known biological activity, therapeutic relevance, or role in disease, diagnosis, or drug interaction. Pseudogenes such as RPL7AP63 are typically not considered valid drug targets, receptors, enzymes, or transporters; they are remnants of gene duplication or retrotransposition events and have lost their protein-coding capability. There is no evidence that RPL7AP63 is involved in any disease process or can be modulated by drugs.

Other names
RPL7A_28_1503RPL7AP63

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 63 (RPL7AP63).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 63 (RPL7AP63).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call